Novosanis, a spin-off of the University of Antwerp, and DDL Diagnostic Laboratory investigated the detection of human papillomavirus (HPV) in first-void urine.
The European Commission granted a “Seal of Excellence” to Novosanis’ project proposal UROSCREEN on the use of Colli-Pee in cervical screening programs.
The European Commission granted a “Seal of Excellence” to Novosanis’ project proposal UROSCREEN on the use of Colli-Pee in cervical screening programs.
De Europese Commissie kende een “Seal of Excellence” toe aan het projectvoorstel UROSCREEN van Novosanis, gericht op het gebruik van Colli-Pee in bevolkingsonderzoek naar...
ANTWERP. POWERED BY CREATIVES. unites award-winning designers during their annual exposition . Novosanis and Voxdale were invited to showcase their innovative health care designs: Colli-Pee...
ANTWERP. POWERED BY CREATIVES. unites award-winning designers during their annual exposition. Novosanis and Voxdale were invited to showcase their innovative designs in regard to health...
As our company has reached a new stage and is generating first commercial sales of its Colli-Pee device, our team needed to grow to meet these new requirements. We proudly present our new...
Novosanis closed a new round of financing. The share capital was increased by a combined cash contribution from current investor Taste Invest and from the Novosanis management team. This...
Graag nodigen we u uit op het allereerste MedTech Flanders Café, op woensdag 30 september vanaf 18h . LOCATIE Novosanis en Voxdale Bijkhoevelaan 32c 2110 Wijnegem
Novosanis is proud to receive funding from the European Commission (Horizon 2020). The grant allows exploring strategies to successfully launch the Colli-Pee™ device to specifically reach...
Novosanis
